Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure

被引:6
|
作者
Liu, Qi [1 ]
Gao, Juan [2 ]
Deng, Jiali [1 ]
Xiao, Junjie [1 ,2 ]
机构
[1] Shanghai Univ, Inst Cardiovasc Sci, Cardiac Regenerat & Ageing Lab, Sch Life Sci, Shanghai, Peoples R China
[2] Shanghai Univ, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2020年 / 7卷
基金
中国国家自然科学基金;
关键词
exercise; muscle; atrophy; therapy; targets; SKELETAL-MUSCLE; RESISTANCE EXERCISE; SATELLITE CELLS; AUTOPHAGY; FITNESS; INTERVENTION; MITOCHONDRIA; INFLAMMATION; ACTIVATION; CAPACITY;
D O I
10.3389/fcvm.2020.593429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Muscle atrophy is a common complication of heart failure. At present, there is no specific treatment to reverse the course of muscle atrophy. Exercise training, due to the safety and easy operation, is a recommended therapy for muscle atrophy induced by heart failure. However, the patients with muscle atrophy are weak in mobility and may not be able to train for a long time. Therefore, it is necessary to explore novel targets of exercise protection for muscle atrophy, so as to improve the quality of life and survival rate of patients with muscular atrophy induced by heart failure. This article aims to review latest studies, summarize the evidence and limitations, and provide a glimpse into the future of exercise for the treatment of muscle atrophy induced by heart failure. We wish to highlight some important findings about the essential roles of exercise sensors in muscle atrophy induced by heart failure, which might be helpful for searching potential therapeutic targets for muscle wasting induced by heart failure.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Exercise Training as Therapy for Heart Failure Current Status and Future Directions
    Fleg, Jerome L.
    Cooper, Lawton S.
    Borlaug, Barry A.
    Haykowsky, Mark J.
    Kraus, William E.
    Levine, Benjamin D.
    Pfeffer, Marc A.
    Pina, Ileana L.
    Poole, David C.
    Reeves, Gordon R.
    Whellan, David J.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2015, 8 (01) : 209 - 220
  • [2] Autophagy and Exercise: Current Insights and Future Research Directions
    Botella, Javier
    Shaw, Christopher S.
    Bishop, David J.
    INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2024, 45 (03) : 171 - 182
  • [3] Exercise Training in Heart Failure: Current Evidence and Future Directions
    Eleyan, Loay
    Gonnah, Ahmed R.
    Farhad, Imran
    Labib, Aser
    Varia, Alisha
    Eleyan, Alaa
    Almehandi, Abdullah
    Al-Naseem, Abdulrahman O.
    Roberts, David H.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [4] Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: Impact of exercise training
    Gallagher, Harrison
    Hendrickse, Paul W.
    Pereira, Marcelo G.
    Bowen, T. Scott
    JOURNAL OF SPORT AND HEALTH SCIENCE, 2023, 12 (05) : 557 - 567
  • [5] Exercise-Induced Mitophagy in Skeletal Muscle and Heart
    Guan, Yuntian
    Drake, Joshua C.
    Yan, Zhen
    EXERCISE AND SPORT SCIENCES REVIEWS, 2019, 47 (03): : 151 - 156
  • [6] Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
    Bharathi Upadhya
    Mark J. Haykowsky
    Dalane W. Kitzman
    Heart Failure Reviews, 2018, 23 : 609 - 629
  • [7] Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
    Upadhya, Bharathi
    Haykowsky, Mark J.
    Kitzman, Dalane W.
    HEART FAILURE REVIEWS, 2018, 23 (05) : 609 - 629
  • [8] Skeletal muscle inflammation and atrophy in heart failure
    Kory J. Lavine
    Oscar L. Sierra
    Heart Failure Reviews, 2017, 22 : 179 - 189
  • [9] Skeletal muscle inflammation and atrophy in heart failure
    Lavine, Kory J.
    Sierra, Oscar L.
    HEART FAILURE REVIEWS, 2017, 22 (02) : 179 - 189
  • [10] Exercise-Induced Mitochondrial Adaptations in Addressing Heart Failure
    Marquez, Jubert
    Han, Jin
    EXERCISE FOR CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT: FROM MOLECULAR TO CLINICAL, PT 2, 2017, 1000 : 323 - 332